Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

NCT00113646 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Expiration of MEDI-507

Conditions

Lymphoma
Leukemia
Multiple Myeloma
Myelodysplastic Syndrome

Interventions

DRUG: MEDI-507
PROCEDURE: Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]